The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus

Antimicrobial Agents and Chemotherapy

Volumn 51, Issue 12, 2007, Pages 4480-4483

  Smith, Eileen C J ^a   Kaatz, Glenn W ^b,c   Seo, Susan M ^c   Wareham, Neale ^d   Williamson, Elizabeth M ^e   Gibbons, Simon ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b John D Dingell Department of Veteran's Affairs Medical Center   (United States)

^c WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Stiefel International R and D   (United Kingdom)

^e UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; DITERPENE; ERYTHROMYCIN; ETHIDIUM; NORA PROTEIN; NORFLOXACIN; RESERPINE; TETRACYCLINE; TOTAROL; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; FEMALE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; DITERPENES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; MICROBIAL SENSITIVITY TESTS; MOLECULAR STRUCTURE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; STAPHYLOCOCCUS AUREUS;

EID: 36749087505     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00216-07     Document Type: Article

References (31)

1. Augustin, J., R. Rosenstein, B. Weiland, U. Schneider, N. Schell, G. Engelke, K. Entian, and F. Götz. 1992. Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis. Eur. J. Biochem. 204:1149-1154.
2. Ball, A. R., G. Casadei, S. Samosom, J. B. Bremner, F. M. Ausubel, T. I. Moy, and K. Lewis. 2006. Conjugating berberine to a multidrug efflux pump inhibitor creates an effective antimicrobial. ACS Chem. Biol. 1:594-600.
3. Clarkson, C., C. C. Musonda, K. Chibale, W. E. Campbell, and P. Smith. 2003. Synthesis of totarol amino alcohol derivatives and their antiplasmodial activity and cytotoxicity. Bioorg. Med. Chem. 11:4417-4422.
4. Eliopoulos, G. M., and R. C. Moellering, Jr. 1991. Antimicrobial combinations, p. 432-492. In V. Lorian (ed.), Antibiotics in laboratory medicine. Williams and Wilkins, Baltimore, MD.
5. Evans, G. B., R. H. Furneaux, G. J. Gainsford, and M. P. Murphy. 2000. The synthesis and antibacterial activity of totarol derivatives. 3. Modification of ring-B. Bioorg. Med. Chem. 8:1663-1675.
6. Foster, T. J. 1998. Molecular genetic analysis of staphylococcal virulence. Methods Microbiol. 27:433-454.
7. Gibbons, S., and E. E. Udo. 2000. The effect of reserpine, a modulator of multidrug efflux pumps, on the in vitro activity of tetracycline against clinical isolates of methicillin resistant Staphylococcus aureus (MRSA) possessing the tet(K) determinant. Phytother. Res. 14:139-140.
8. Haraguchi, H., H. Ishikawa, and I. Kubo. 1996. Mode of antibacterial action of totarol, a diterpene from Podocarpus nagi. Planta Med. 62:122-125.
9. Jaiswal, R., T. K. Beuria, R. Mohan, S. K. Mahajan, and D. Panda. 2007. Totarol inhibits bacterial cytokinesis by perturbing the assembly dynamics of FtsZ. Biochemistry 46:4211-4220.
10. Kaatz, G. W., S. I. Barriere, D. R. Schaberg, and R. Fekety. 1987. The emergence of resistance to ciprofloxacin during therapy of experimental methicillin-susceptible Staphylococcus aureus endocarditis. J. Antimicrob. Chemother. 20:753-758.
11. Kaatz, G. W., S. M. Seo, and C. A. Ruble. 1993. Efflux-mediated fluoroquinolone resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 37:1086-1094.
12. Kaatz, G. W., S. M. Seo, L. O'Brien, M. Wahiduzzaman, and T. J. Foster. 2000. Evidence for the existence of a multidrug efflux transporter distinct from NorA in Staphylococcus aureus. Antimicrob. Agents Chemother. 44:1404-1406.
13. Kaatz, G. W. 2005. Bacterial efflux pump inhibition: a potential means to recover clinically relevant activity of substrate antimicrobial agents. Curr. Opin. Investig. Drugs 6:191-198.
14. Kubo, I., H. Muroi, and M. Himejima. 1992. Antibacterial activity of totarol and its potentiation. J. Nat. Prod. 55:1436-1440.
15. Lomovskaya, O., and K. A. Bostian. 2006. Practical applications and feasibility of efflux pump inhibitors in the clinic - a vision for applied use. Biochem. Pharmacol. 71:910-918.
16. Markham, P. N., and A. A. Neyfakh. 1996. Inhibition of the multidrug transporter NorA prevents emergence of norfloxacin resistance in Staphylococcus aureus. Antimicrob. Agents Chemother. 40:2673-2674.
17. Markham, P. N., E. Westhaus, K. Klyachko, M. E. Johnson, and A. A. Neyfakh. 1999. Multiple novel inhibitors of the NorA multidrug transporter of Staphylococcus aureus. Antimicrob. Agents Chemother. 43:2404-2408.
18. Micol, V., C. R. Mateo, S. Shapiro, F. J. Aranda, and J. Villalain. 2001. Effects of (+)-totarol, a diterpenoid antibacterial agent, on phospholipid model membranes. Biochim. Biophys. Acta 1511:281-290.
19. Mossa, J. S., F. S. El-Feraly, and I. Muhammad. 2004. Antimycobacterial constitutents from Juniperus procera, Ferula communis and Plumbago zeylanica and their in vitro synergistic activity with isonicotinic acid hydrazide. Phytother. Res. 18:934-937.
20. Muroi, H., and I. Kubo. 1996. Antibacterial activity of anacardic acid and totoral, alone and in combination with methicillin against methicillin-resistant Staphylococcus aureus. J. Appl. Bacteriol. 80:387-394.
21. Neyfakh, A. A., C. M. Borsch, and G. W. Kaatz. 1993. Fluoroquinolone resistance protein NorA of Staphylococcus aureus is a multidrug efflux transporter. Antimicrob. Agents Chemother. 37:128-129.
22. Nicolson, K., G. Evans, and P. W. O'Toole. 1999. Potentiation of methicillin activity against methicillin-resistant Staphylococcus aureus by diterpenes. FEMS Microbiol. Lett. 179:233-239.
23. Nishida, T., I. Wahlberg, and C. R. Enzell. 1977. Carbon-13 nuclear magnetic resonance spectra of some aromatic diterpenoids. Org. Mag. Reson. 9:203.209.
24. Piddock, L. J. V. 2006. Multidrug-resistance efflux pumps - not just for resistance. Nat. Rev. Microbiol. 4:629-636.
25. Price, C. T. D., G. W. Kaatz, and J. E. Gustafson. 2002. The multidrug efflux pump NorA is not required for salicylate-induced reduction in drug accumulation by Staphylococcus aureus. Int. J. Antimicrob. Agents 20:206-213.
26. Reynolds, E., J. I. Ross, and J. H. Cove. 2003. Msr(A) and related macrolide/streptogramin resistance determinants: incomplete transporters? Int. J. Antimicrob. Agents 22:228-236.
27. Richardson, J. F., and S. Reith. 1993. Characterisation of a strain of methicillin-resistant Staphylococcus aureus (EMRSA-15) by conventional and molecular methods. J. Hosp. Infect. 25:45-52.
28. Shapiro, S., and B. Guggenheim. 1998. Inhibition of oral bacteria by phenolic compounds. 1. QSAR analysis using molecular connectivity. Quant. Struct. Activity Relationships 17:327-337.
29. Smith, E., E. Williamson, M. Zloh, and S. Gibbons. 2005. Isopimaric acid from Pinus nigra shows activity against multidrug-resistant and EMRSA strains of Staphylococcus aureus. Phytother. Res. 19:538-542.
30. Tegos, G., F. R. Stermitz, O. Lomovskaya, and K. Lewis. 2002. Multidrug pump inhibitors uncover remarkable activity of plant antimicrobials. Antimicrob. Agents Chemother. 46:3133-3141.
31. Zloh, M., G. W. Kaatz, and S. Gibbons. 2004. Inhibitors of multidrug resistance (MDR) have affinity for MDR substrates. Bioorg. Med. Chem. Lett. 14:881-885.